stay up to date on this topic
by: emma spears
almost 18 months into the global covid-19 pandemic, the list of risk factors for experiencing severe symptoms of the virus is continuing to expand.
people with chronic health conditions such as asthma, obesity or sickle cell disease, those who smoke tobacco and individuals over the age of 65 are known to be at an increased risk of a poor outcome, per resources such as the
b.c. centre for disease control, the
canadian government and the
mayo clinic. but authors of the new research suggest that those who engage in “problematic cannabis use” may also be at an elevated risk.
investigators employed genetic epidemiological models to gauge whether or not a genetic predisposition to cud may be related to an increased risk of severe reaction, such as hospitalization, to the virus.
the authors combined existing datasets to determine if a genetic predisposition to cud correlated with a higher risk of hospitalization from covid-19, using two sets of data. one of these involved 357,806 subjects, 14,080 of whom were diagnosed with cud; the second involved more than 1.2 million subjects, 9,373 of whom were hospitalized as a result of the virus.
in all, 7 million genetic variants were also studied to assess an association between severe symptoms of the virus and cud, the researchers report.
“problematic cannabis use and vulnerability to serious covid-19 complications share genetic underpinnings that are unique from common correlates,” writes lead author alexander hatoum, a postdoctoral researcher at the washington university school of medicine. “while cud may plausibly contribute to severe covid-19 presentations, causal inference models yielded no evidence of putative causation,” hatoum points out.